Connection

Adam Harrington to Caenorhabditis elegans

This is a "connection" page, showing publications Adam Harrington has written about Caenorhabditis elegans.
Connection Strength

0.995
  1. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. J Neurosci. 2012 Feb 08; 32(6):2142-53.
    View in: PubMed
    Score: 0.392
  2. Caenorhabditis elegans as a model system for identifying effectors of a-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease. Methods. 2011 Mar; 53(3):220-5.
    View in: PubMed
    Score: 0.363
  3. Modeling dopamine neuron degeneration in Caenorhabditis elegans. Methods Mol Biol. 2011; 793:129-48.
    View in: PubMed
    Score: 0.091
  4. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev Dyn. 2010 May; 239(5):1282-95.
    View in: PubMed
    Score: 0.087
  5. Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. J Neurochem. 2010 Aug; 114(4):1193-204.
    View in: PubMed
    Score: 0.022
  6. VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease. Neurobiol Dis. 2010 Feb; 37(2):330-8.
    View in: PubMed
    Score: 0.021
  7. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. J Vis Exp. 2008 Jul 18; (17).
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.